Qualitative and quantitative analysis of the bioactive components of "ginseng-polygala" drug pair against PC12 cell injury based on UHPLC-QTOF-MS and HPLC

Aβ25-35-induced PC12 cells were used as the in vitro injury model to evaluate the effects on PC12 cells after intervention with the "ginseng-polygala" drug pair. The results showed that the drug pair could significantly increase cell activity and reduce the level of reactive oxygen species...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengyang Wang (Author), Xiaomeng Sun (Author), Yue Zhao (Author), Liba Ga (Author), Qi Li (Author), Qian Li (Author), Xiaotong Wang (Author), Chunjuan Yang (Author)
Format: Book
Published: Frontiers Media S.A., 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8c2c8dda9fde42d58d49a327cd8fb645
042 |a dc 
100 1 0 |a Zhengyang Wang  |e author 
700 1 0 |a Xiaomeng Sun  |e author 
700 1 0 |a Yue Zhao  |e author 
700 1 0 |a Liba Ga  |e author 
700 1 0 |a Qi Li  |e author 
700 1 0 |a Qian Li  |e author 
700 1 0 |a Xiaotong Wang  |e author 
700 1 0 |a Chunjuan Yang  |e author 
245 0 0 |a Qualitative and quantitative analysis of the bioactive components of "ginseng-polygala" drug pair against PC12 cell injury based on UHPLC-QTOF-MS and HPLC 
260 |b Frontiers Media S.A.,   |c 2022-12-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2022.949757 
520 |a Aβ25-35-induced PC12 cells were used as the in vitro injury model to evaluate the effects on PC12 cells after intervention with the "ginseng-polygala" drug pair. The results showed that the drug pair could significantly increase cell activity and reduce the level of reactive oxygen species and the concentration of inflammatory factors to improve the Alzheimer's disease treatment process. Furthermore, to rapidly identify and classify complicated bioactive components of the drug pair, a liquid chromatography with quadrupole time-of-flight mass spectrometry method combined with a molecular network strategy was established. With this strategy, 40 constituents were preliminarily identified and a database of the compounds was successfully established. Among them, 12 compounds of different categories were accurately identified by comparison with reference substances. The content of the aforementioned active components was simultaneously determined by HPLC to control the quality of compatible medicinal materials, and the verification results of the analytical method met the content determination requirements. The results revealed that after compatibility, the content change of the components is not the simple addition of quantity but the comprehensive effect of the two medicines. In conclusion, this study could provide a generally applicable strategy for pharmacological activity, structural identification, and content determination in traditional Chinese medicine and its compatibility. 
546 |a EN 
690 |a "ginseng-polygala" drug pair 
690 |a high-resolution mass spectrometry 
690 |a structural identification 
690 |a quality control 
690 |a data processing 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 13 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2022.949757/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/8c2c8dda9fde42d58d49a327cd8fb645  |z Connect to this object online.